Latest Period
Q2 2026
Security Snapshot
Structure Therapeutics Inc. - COMMON STOCK (GPCR) Institutional Ownership
CUSIP: 86366E106
13F Institutional Holders and Ownership History from Q1 2023 to Q2 2026
Institutions Reporting
192
Shares (Excl. Options)
67,559,599
Price
$53.67
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK
- Symbol
- GPCR on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 67,559,599
- Total 13F value
- $3,622,549,992
- Portfolio coverage rank
- 0.01%
- Share change
- +987,093
- Value change
- +$65,031,904
- Number of holders
- 192
- Shares outstanding
- 213,616,432
- SEC-reported price per share
- $46.03
- Insider filing price
- $46.03
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- GPCR - Structure Therapeutics Inc. - COMMON STOCK is tracked under CUSIP 86366E106.
- 192 institutions reported positions in Q2 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 195 to 192 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $3,215,748,317 to $3,622,549,992.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 192 institutions filings for Q2 2026.
Security key
86366E106
Latest holder period
Q2 2026
13F holders
192
13D/G owners
7
CIK / CUSIP context first
Open Q2 2026 holders
GPCR full holder history
Structure Therapeutics Inc. SEC filings
Structure Therapeutics Inc. company facts
Structure Therapeutics Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 86366E106:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
GPCR
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 13% | -12% | $1,554,802,927 | -$160,747,712 | 28,197,369 | -9.4% | FMR LLC | 30 Jun 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 10% | -15% | $1,481,942,431 | +$50,941,729 | 21,365,952 | +3.6% | Wellington Management Group LLP | 31 Dec 2025 |
| Avoro Capital Advisors LLC | 9.4% | $454,066,620 | 16,216,665 | Avoro Capital Advisors LLC | 30 Sep 2025 | |||
| Deep Track Capital, LP | 6% | -20% | $855,579,599 | -$21,646,354 | 12,335,346 | -2.5% | Deep Track Capital, LP | 31 Dec 2025 |
| BIOTECHNOLOGY VALUE FUND L P | 4.9% | -12% | $723,914,898 | +$57,243,848 | 10,437,066 | +8.6% | BVF PARTNERS L P/IL | 31 Dec 2025 |
| Capital Research Global Investors | 3.8% | $168,218,991 | 6,492,435 | Capital Research Global Investors | 31 Mar 2025 | |||
| JANUS HENDERSON GROUP PLC | 7.7% | -3.8% | $124,567,128 | -$3,477,040 | 4,448,826 | -2.7% | JANUS HENDERSON GROUP PLC | 30 Sep 2025 |
As of 30 Jun 2026, 192 institutional investors reported holding 67,559,599 shares of Structure Therapeutics Inc. - COMMON STOCK (GPCR). This represents 32% of the company’s total 213,616,432 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
27%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 3.7% | 7,810,306 | -7.1% | 0.02% | $419,179,123 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.5% | 7,379,433 | +1.6% | 0.07% | $396,054,169 |
| Avoro Capital Advisors LLC | 3.1% | 6,555,555 | 0% | 3.2% | $351,836,637 |
| Jupiter Topco LLC | 2.4% | 5,204,212 | 0% | 0.11% | $279,339,383 |
| Deep Track Capital, LP | 2.2% | 4,740,072 | +11% | 3.7% | $254,399,664 |
| BVF INC/IL | 1.6% | 3,366,823 | -2.7% | 4.6% | $180,697,390 |
| MORGAN STANLEY | 1.3% | 2,806,640 | +22% | 0.01% | $150,632,372 |
| ORBIMED ADVISORS LLC | 1% | 2,209,400 | +50% | 2.2% | $118,578,498 |
| PRINCIPAL FINANCIAL GROUP INC | 0.82% | 1,752,753 | -0.06% | 0.05% | $94,070,254 |
| AMERICAN CENTURY COMPANIES INC | 0.79% | 1,682,179 | +17% | 0.04% | $90,282,956 |
| RTW INVESTMENTS, LP | 0.75% | 1,607,507 | 0.74% | $86,274,901 | |
| Driehaus Capital Management LLC | 0.73% | 1,553,219 | -1.5% | 0.48% | $83,361,264 |
| BAKER BROS. ADVISORS LP | 0.67% | 1,432,529 | 0% | 0.39% | $76,883,831 |
| Casdin Capital, LLC | 0.55% | 1,175,000 | 0% | 3.2% | $63,062,250 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 0.51% | 1,086,000 | +41% | 0.61% | $58,285,620 |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | 0.49% | 1,041,100 | -9.6% | 0.24% | $55,875,837 |
| Siren, L.L.C. | 0.41% | 872,967 | -34% | 0.95% | $46,852,139 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.4% | 845,532 | -58% | 0% | $45,380,000 |
| Pacific Heights Asset Management LLC | 0.37% | 800,000 | +6.7% | 1.4% | $42,936,000 |
| Rock Springs Capital Management LP | 0.3% | 640,317 | +0.02% | 1.7% | $34,365,813 |
| Aberdeen Group plc | 0.3% | 639,915 | +63% | 0.05% | $34,344,238 |
| ALLIANCEBERNSTEIN L.P. | 0.29% | 611,708 | -4.2% | 0.01% | $29,484,326 |
| FRANKLIN RESOURCES INC | 0.27% | 578,839 | +8.9% | 0.01% | $31,066,308 |
| BANK OF AMERICA CORP /DE/ | 0.26% | 563,422 | +148% | 0% | $30,238,858 |
| BlackRock, Inc. | 0.24% | 511,149 | +16% | 0% | $27,433,368 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
14
Latest
Q2 2026
Rows shown
1-14 of 14
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 67,559,599 | $3,622,549,992 | +$65,031,904 | $53.67 | 192 |
| 2026 Q1 | 66,450,436 | $3,215,748,317 | -$49,596,066 | $48.20 | 195 |
| 2025 Q4 | 65,776,439 | $4,580,197,295 | +$791,360,837 | $69.55 | 197 |
| 2025 Q3 | 56,638,847 | $1,582,549,935 | +$86,587,271 | $28.00 | 155 |
| 2025 Q2 | 54,653,188 | $1,133,630,623 | -$12,998,783 | $20.74 | 172 |
| 2025 Q1 | 55,933,663 | $980,564,651 | -$97,541,400 | $17.31 | 150 |
| 2024 Q4 | 60,660,143 | $1,645,431,741 | -$123,990,833 | $27.12 | 162 |
| 2024 Q3 | 61,353,442 | $2,685,754,151 | +$108,882,886 | $43.89 | 160 |
| 2024 Q2 | 59,255,636 | $2,326,748,242 | +$609,713,327 | $39.27 | 164 |
| 2024 Q1 | 43,607,566 | $1,861,796,908 | +$49,174,094 | $42.86 | 119 |
| 2023 Q4 | 42,586,066 | $1,736,374,072 | +$365,354,803 | $40.76 | 121 |
| 2023 Q3 | 32,752,287 | $1,641,782,565 | +$750,250,715 | $50.42 | 83 |
| 2023 Q2 | 17,647,287 | $699,362,453 | +$105,685,176 | $41.57 | 48 |
| 2023 Q1 | 14,419,544 | $343,038,725 | +$343,038,726 | $23.79 | 38 |